MAVERICK SIMULATION SOLUTIONS Unlisted Shares

Maverick Simulation Solutions Ltd. (MSSL) is one of India's most innovative companies in the medical simulation and training technology space — building a product portfolio that ranges from AI-powered patient simulators and autonomous lung simulators to surgical training systems, anatomage (3D anatomy dissection tables), and specialised engineering simulation tools. Maverick Simulation unlisted shares are available through Valowth Capital — contact us for current pricing and availability.

The company was originally founded as Maveric Solutions Inc. in 2006 as a 3D scanning and printing venture. In 2019, the management made a strategic pivot into the medical and healthcare simulation industry — a decision driven by the enormous unmet need for affordable, high-quality clinical training in India's rapidly growing healthcare sector. In September 2023, the company became a public limited company, signalling its intent to scale and eventually list.

Maverick's product portfolio is genuinely impressive for an Indian company. Key products include autonomous human lung simulators that replicate real respiratory physiology, AI-powered patient simulators capable of replicating clinical scenarios, surgical simulators for procedural skill training, and anatomage tables that enable immersive digital dissection without physical cadavers. Engineering simulation tools including IVFsim Pro, NurseSim Pro, and FaceSim Pro round out a portfolio that serves both medical education and advanced clinical training needs.

Why Maverick Simulation Solutions unlisted shares represent a high-conviction opportunity:India has one of the world's largest medical education sectors — with hundreds of medical colleges, thousands of nursing institutions, and a rapidly growing healthcare workforce. Yet clinical training quality has historically been constrained by limited access to real patients, ethical restrictions on cadaver use, and geographic concentration of quality training infrastructure.

Simulation technology directly solves all of these problems — allowing students and clinicians to practice procedures repeatedly, safely, and measurably. As India's medical education regulatory framework (NMC regulations) increasingly mandates simulation-based training, demand for MSSL's products will grow structurally and durably.

The defence and paramilitary training dimension adds another high-value customer segment. Military medical training, first responder preparedness, and disaster management all require the kind of high-fidelity simulation that MSSL produces.

MSSL's "Made in India" positioning is strategically important — imported medical simulators from US and European companies are priced at 5-10x what Indian institutions can afford. MSSL's domestic manufacturing capability allows it to price competitively while maintaining international quality standards through collaborations with global technology partners.

Founder-financed and organically profitable, MSSL has built its business without equity dilution — a discipline that preserves value for eventual shareholders and signals strong unit economics.

Valowth Capital provides verified demat-based transfer of Maverick Simulation Solutions unlisted shares. Contact us for current price and lot availability.

Tax: LTCG (24+ months) = 20% with indexation. STCG = per income slab. No STT on unlisted transactions.